Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19
NCT04344080
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DEVICE:
CytoSorb-Therapy
Sponsor
Universitätsklinikum Hamburg-Eppendorf